RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xilio Therapeutics Stock

Xilio Therapeutics Equity 2024

Xilio Therapeutics Equity

36.83 M USD

Ticker

XLO

ISIN

US98422T1007

In 2024, Xilio Therapeutics's equity was 36.83 M USD, a -65.13% increase from the 105.6 M USD equity in the previous year.

Xilio Therapeutics Aktienanalyse

What does Xilio Therapeutics do?

Xilio Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Xilio Therapeutics's Equity

Xilio Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Xilio Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Xilio Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Xilio Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Xilio Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Xilio Therapeutics stock

What is the equity of Xilio Therapeutics this year?

Xilio Therapeutics has equity of 36.83 M USD this year.

What was the equity of Xilio Therapeutics compared to the previous year?

The equity of Xilio Therapeutics has increased/decreased by -65.13% decreased compared to the previous year.

What impact does a high equity have on investors of Xilio Therapeutics?

A high equity is advantageous for investors of Xilio Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Xilio Therapeutics?

A low equity can be a risk for investors of Xilio Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Xilio Therapeutics affect the company?

An increase in equity of Xilio Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Xilio Therapeutics affect the company?

A reduction in equity of Xilio Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Xilio Therapeutics?

Some factors that can affect the equity of Xilio Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Xilio Therapeutics so important for investors?

The equity of Xilio Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Xilio Therapeutics take to change the equity?

To change equity, Xilio Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Xilio Therapeutics pay?

Over the past 12 months, Xilio Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xilio Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Xilio Therapeutics?

The current dividend yield of Xilio Therapeutics is .

When does Xilio Therapeutics pay dividends?

Xilio Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xilio Therapeutics?

Xilio Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Xilio Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xilio Therapeutics located?

Xilio Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xilio Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xilio Therapeutics from 11/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/10/2024.

When did Xilio Therapeutics pay the last dividend?

The last dividend was paid out on 11/10/2024.

What was the dividend of Xilio Therapeutics in the year 2023?

In the year 2023, Xilio Therapeutics distributed 0 USD as dividends.

In which currency does Xilio Therapeutics pay out the dividend?

The dividends of Xilio Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xilio Therapeutics

Our stock analysis for Xilio Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xilio Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.